Embolization

Children

*Developer of a medical device for embolization procedures
*Developer of a peripheral embolization device to treat cardiovascular disease for the occlusion of peripheral vessels.
*Embol-X
*Specialize in the Design and Manufacturing of Medical Inflation Devices, Therapeutic Catheters, Thrombolytic Catheters, Diagnostic and Hydrophilic Products, Fluid Dispensing Systems, Embolotherapeutic Products
1-Next-generation liquid embolic for treating cerebral aneurysms and arteriovenous malformations (AVMs)
2010: U.S. Navy_65--Guidewires, Catheters, and Embolization Coils: Presolicitation (2010)
2011: CAD may boost CT detection of pulmonary embolism (2011)
2018: Embolx wins $2m NIH grant for pressure-directed embolization therapy
2022: Viking Therapeutics: Potential To Embolden Itself In NASH Space_ seekingalpha.com
2024: Nearing completion of enrollment in an FDA investigational device exemption (IDE) trial evaluating pulmonary embolism (PE) patients
2024: Praxis Precision Medicines announces positive topline results from the EMBOLD study in SCN2A and 8A developmental epilepsies, highlighting the disease-modifying potential of relutrigine
A new bioresorbable embolic bead technology blocks blood vessels supplying tumors without causing long term blockage of the blood vessels of healthy tissue.
Aortic embolic protection device for acute and long-term use
BioCure
Biocure, a company specializing in embolotherapy, orthopedics, and wound care is currently developing SprayGel©, a hydrogel that comes in spray form that releases nitric oxide
BioSphere develops and markets embolotherapeutic products for the treatment of uterine fibroids, hypervascularized tumors, and arteriovenous malformations.
BioSphere Medical
CardioGard develops a single-patient-use device for removal of embolic material during open heart surgery
CardioGard is developing a specially designed arterial (aortic) cannula for use in cardiac surgery for the purpose of removal of gaseous and solid embolic material emanating during aortic manipulations.
EKOS's EkoSonic Endovascular System Gets European Clearance to Treat Pulmonary Embolism (2011)
Emboli containment systems for use during vascular interventional therapies
Embolic Protection Systems
Embolic Protection Systems=$70 million, (2001)
Embolics
Embolotherapy has become an accepted alternative for many women suffering from uterine fibroids who may otherwise undergo a hysterectomy.
Embolotherapy procedures are primarily performed by interventional radiologists and use bioengineered microspheres to create targeted vascular occlusion and drug delivery.
Embolx
embolx.com
EmboMedics
Finalizing the development of a novel embolic protection device designed for use during Transcatheter Aortic Valve Implantation (TAVI) procedures.
It is a central venous catheter and Inferior Vena Cava filter combination device that’s intended to protect against potentially fatal pulmonary embolism in critically ill patients.
It’s the first time an endovascular device—which uses a catheter to slide inside arteries—has won approval to fight pulmonary embolisms in Europe
LaNua Medical
Marval’s agents remain in the circulation for hours, facilitating continuous follow-up imaging in patients with evolving vascular crises including myocardial infarcts, stroke, and pulmonary emboli.
Potential markets include traumatic brain injury, carbon monoxide poisoning, surgical air embolism, trauma, wound care, decompre
PROXIS, a unique and proprietary system for embolic protection
RAD Technology Medical Systems
Rapid Imaging of Pulmonary Emboli and Deep-Vein Thrombi with Radiolabelled Disintegrins-Temple University
Similarly, with 600,000 new cases of primary liver cancer per year, there is growing international adoption of embolotherapy with drug-delivery protocols to treat liver cancer.
SMT Research and Development Ltd. Announces Financing to Pursue Development of Novel Embolic Protection Device for Use in TAVI Procedures
The company designed the device to enable "faster, safer and simpler over-wire insertion of sheaths and cathetors" and reduce "the risks of lost cannulation, contamination, embolism and accidental needlestick injury,"
The Ekosonic system has won approval from regulators in the European Union as a treatment for pulmonary embolisms.
The IQCath™ Balloon Dilatation Catheter, GPSCath™ Balloon Dilatation Catheter, and the Keeper™ Embolectomy Catheter received 510(k) clearance from the FDA in July 2010 and became commercially available in the U.S. in December 2010.
The network conducts clinical trials in a breadth of emergency indications related to neurology (e.g., status epilepticus, traumatic brain injury and spinal cord injury), cardiovascular (e.g., cardiac arrest, decompensation of cardiac failure), respiratory (e.g., respiratory arrest, pulmonary embolus), hematology (e.g., exsanguination) and trauma.
The Surefire™ Infusion System is designed to precisely deliver embolic agents through the sophisticated expandable tip portion of its catheter.
Uterine Artery Embolization

Made with TheBrain